Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation.
View / Open Files
Authors
Publication Date
2021-12-10Journal Title
Sci Adv
ISSN
2375-2548
Publisher
American Association for the Advancement of Science (AAAS)
Volume
7
Issue
50
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
West, J., Satapathy, S., Whiten, D. R., Kelly, M., Geraghty, N. J., Proctor, E., Sormanni, P., et al. (2021). Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation.. Sci Adv, 7 (50) https://doi.org/10.1126/sciadv.abf7606
Abstract
Neuroserpin is a secreted protease inhibitor known to inhibit amyloid formation by the Alzheimer’s beta peptide (Aβ). To test whether this effect was constrained to Aβ, we used a range of in vitro assays to demonstrate that neuroserpin inhibits amyloid formation by several different proteins and protects against the associated cytotoxicity but, unlike other known chaperones, has a poor ability to inhibit amorphous protein aggregation. Collectively, these results suggest that neuroserpin has an unusual chaperone selectivity for intermediates on the amyloid-forming pathway. Bioinformatics analyses identified a highly conserved 14-residue region containing an α helix shared between neuroserpin and the thyroxine-transport protein transthyretin, and we subsequently demonstrated that transthyretin also preferentially inhibits amyloid formation. Last, we used rationally designed neuroserpin mutants to demonstrate a direct involvement of the conserved 14-mer region in its chaperone activity. Identification of this conserved region may prove useful in the future design of anti-amyloid reagents.
Identifiers
34890220, PMC8664251
External DOI: https://doi.org/10.1126/sciadv.abf7606
This record's URL: https://www.repository.cam.ac.uk/handle/1810/333115
Rights
Attribution-NonCommercial 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk